Inhibition of NLRP3 inflammasome activity by MCC950 leads to exacerbation of SjÓ§gren's syndrome pathologies in non-obese diabetic mice. Zhou J, Onodera S, Yu Q. Immunology 2023;168:697-708.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhou J, Onodera S, Yu Q. Inhibition of NLRP3 inflammasome activity by MCC950 leads to exacerbation of SjÓ§gren's syndrome pathologies in non-obese diabetic mice. Immunology 2023;168:697-708.
PMID: 36353754